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	ABSTRACT 
 
The primary bacterial targets for most antibiotics are well known.  To survive the stress 
of an antibiotic a bacterium must decrease the antibiotic to target binding ratio to escape 
from harmful effects.  This can occur through a number of different functions including 
down-regulation of the target, mutation of the binding site on the target, and decreasing 
the intake or increasing the efflux of the antibiotic. However, it is becoming more evident 
that an antibiotic stress response influences more than just the primary target, and that a 
wave of secondary responses can be triggered throughout the bacterium. As a result 
resistance mutations may arise in genes that are indirectly affected by the initial 
interaction between the antibiotic and target. These indirect responses have been found to 
be associated with metabolism, regulation, cell division, oxidative stress, and other 
critical pathways. One technique recently developed in our lab, called transposon 
insertion sequencing (Tn-seq), can be used to further understand the complexity of these 
indirect responses by profiling growth rates (fitness) of mutants at a genome-wide level. 
However, Tn-seq is normally performed with large libraries of pooled mutants and thus it 
remains unclear how this may influence fitness of some independent mutants that may be 
compensated by others in the population. Additionally, since the original method has only 
utilized planktonic culture, it is also not clear how higher order bacterial structures, such 
as biofilms or microcolonies, influence bacterial fitness. To better understand the 
dynamics of pooled versus individual mutant culture, as well as the effect of community 
structure in microcolony development on the influence of fitness, we adapted a droplet 
microfluidics-based technique to encapsulate and culture single mutants.  We were able 
to successfully encapsulate at least 7 different species of bacterial pathogens, including 
	Streptococcus pneumoniae, and culture them planktonically, or as microcolonies, in 
either monodisperse liquid or agarose droplets. These experiments, however, raised an 
important challenge: the DNA yield from one encapsulation experiment is insufficient to 
generate samples for sequencing by means of the traditional Tn-seq method.  This led us 
to develop a novel Tn-seq DNA library preparation method, which is able to generate 
functional Tn-seq library molecules from picogram amounts of DNA. This method is not 
ideal yet because fitness data generated through the new method currently does not 
correlate well with data from traditional Tn-seq library preparation. However, we have 
identified one major culprit that should be easily solvable.  We expect by modifying the 
binding site of the primer used for linear amplification of transposon ends that the new 
preparation method will be able recapitulate results from the traditional Illumina 
preparation method for Tn-seq.  This will enable us to prepare robust Tn-seq samples 
from very small amounts of DNA in order to probe stress responses in single mutants as 
well as in microcolonies in a high-throughput manner. 
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INTRODUCTION 
The problem. 
Antibiotic resistant bacteria are a major health concern with an infectious burden causing 
over 2 million illnesses and 23,000 deaths per year in the United States alone1. This 
overwhelming number of bacterial infections has led to an estimated $35 billion a year in 
direct medical costs and lost economic productivity1,2. There are three major approaches 
that have been applied throughout the past 60 years to try to curb antibiotic resistance and 
its associated cost: 1) vaccine development; 2) phenotypic screens to identify 
compounds with antibiotic properties; 3) bioinformatic analysis of genome 
sequences for rational drug targets and subsequent chemical library screens.  
Vaccine development was a tremendous breakthrough, allowing for the reduction of 
major bacterial infections from pathogens such as Neisseria meningitides, Vibrio cholera, 
Corynebacterium diphtheria, and Streptococcus pneumoniae3.  Although vaccines have 
significantly reduced the number of total bacterial infections, they are often not 100% 
efficacious or fully protective against all pathogenic strains within a species4–7.  Vaccines 
were eventually supplemented with antibiotics, which were identified through phenotypic 
screens during the 1950s and 1960s in what is termed as the “Golden Age of Drug 
Discovery”. Systematic methods were used to test if soil microorganisms harbored 
antibiotic properties against common bacterial pathogens. Many of our current antibiotics 
originate from these screens, but these methods have been mostly abandoned because of 
diminishing returns due to the exhaustive identification of antibiotics with a high 
discovery frequency.  Re-discovery of the same compounds makes it extremely difficult 
to identify novel antimicrobials that are present at extremely low frequency8.  The third 
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approach to curb antibiotic resistance takes advantage of the tens-of-thousands of fully 
sequenced eubacterial genomes that have been generated since the mid-1990s9.  
Bioinformatic identification of conserved bacterial genes, which were tested for growth 
essentiality, produced hundreds of potential drug targets that were screened for 
interactions against large chemical compound libraries. Although this approach has 
produced several promising leads, such as FabI-directed antibiotics10, it has had limited 
success compared to phenotypic screens.  Large pharmaceutical companies who had 
adopted large chemical screens have since mostly abandoned the method9,11. Due to the 
limitations of the above applications we desperately need to find new methods for solving 
the problem of antibiotic resistance in bacteria. So where do we start?  
 
The hypothesis. 
We propose to temporarily zoom out and focus our attention on what actually makes a 
bacterium able to withstand and deal with the stress they experience when challenged 
with an antibiotic. How antibiotics cause bactericidal or bacteriostatic affects is much 
studied and vigorously debated.  It is well known that antibiotics have a primary target, 
mainly DNA, RNA, or protein. Most of the major routes of escape from antibiotics have 
been shown to minimize the interaction between the drug and the bacterium through three 
general mechanisms: 1) reduced influx and increased efflux of the antibiotic, 2) mutation 
at the binding site of the primary target, and 3) targeted break-down of the antibiotic. 
However, clinical strains often show multiple genotypic variations that contribute to 
resistance, but these alterations are located in genes whose primarily role is not 
resistance, and are instead involved in in fundamental bacterial processes. Additionally, 
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data from network biology approaches have shown that the relationship between a 
bacterium and an antibiotic reaches far beyond its direct-target. Instead an antibiotic 
triggers a complex, multi-factorial process that may begin with the physical interaction 
between the drug and its target but quickly propagates into the involvement of a variety 
of processes that can include regulation, metabolism and/or energy generation. These 
data have lead us to hypothesize that a novel antimicrobial strategy could originate 
from a comprehensive understanding of which bacterial genes are involved in 
dealing with a particular antibiotic stress. Genes that become important in the 
presence of an antibiotic are thus potentiating genes that could function as 
secondary targets that make existing antibiotics more powerful. Moreover, these 
stress-responsive genes could also indicate where adaptation is most likely to occur 
in the genome. We thus believe that identification and an in depth analysis of these 
antibiotic stress-related genes is critical in our fight against antibiotic resistant 
bacteria.  
 
The model system. 
In this study we ultimately seek to generate genome-wide stress-response profiles, or 
gene-antibiotic interaction maps (GAIM), for the bacterial pathogen Streptococcus 
pneumoniae. With over 800,000 deaths worldwide, half a million of those being children 
under the age of 5, S. pneumoniae poses a considerable health threat12. Pneumococcal 
diseases such as pneumonia, bacteremia, otitis media, and meningitis, also present a 
serious health risk for the elderly, the immune-compromised, and those people receiving 
organ transplants13. One of the best preventative measures we have for pneumococcal 
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disease is a conjugate vaccine, Prevnar 13, which is only ~60% efficacious14. Moreover, 
it only protects against 13 out of more than 90 pneumococcal serotypes7 and there is a 
concern for serotype replacement15, in which non-vaccine serotypes increase in 
asymptomatic carriage and disease-causing cases. Because of this lack of full protection, 
antibiotics that can broadly target a species remain a necessary defense against S. 
pneumoniae infections. However, as with so many bacterial pathogens the number of 
singly and multiply drug resistant S. pneumonia cases is steadily increasing16–18, 
exacerbating the problem of treating pathogenic infections. 
 
The challenge. 
To accurately identify genome-wide genetic factors involved in an antibiotic stress 
response we first propose to use the systems tool Transposon insertion sequencing (Tn-
seq), which takes advantage of massively parallel sequencing to accurately determine 
genotype-phenotype relationships on a genome wide scale19. We have previously shown 
the broad applicability of Tn-seq by 1) determining fitness cost of all non-essential genes 
and possibly essential genes, in several clinically relevant strains of S. pneumoniae20,21, 2) 
generating high-confidence gene-condition interaction maps for a number of typical 
challenges that pathogenic S. pneumoniae encounter during infection and treatment21, and 
3) proving the functionality of the method in not only in-vitro conditions, but also in-vivo 
mouse models22. However, one limitation of Tn-seq is that mutant libraries are grown in 
batch culture, thereby possibly masking mutants that are outcompeted for available 
resources as well as allowing “cheaters” to survive by taking advantage of overall 
population fitness. Therefore the current Tn-seq technique may not be entirely 
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representative of true mutant fitness, or more importantly, be completely lacking in some 
important mutant data.  Additionally, sequencing sample-preparation requires 
micrograms of DNA, which we discovered to be problematic for the experiments 
proposed below, where only nanograms are available.  
 
The solution. 
We address the limitations of Tn-seq in this study by taking advantage of droplet 
microfluidics to encapsulate and culture complex mutant transposon libraries of bacterial 
cells.  Encapsulation can be performed in such a way that each droplet contains a single 
mutant, and each droplet has its own independent environment. As a result individual 
bacterium within the library can no longer interact with each other, the confounding 
factor of ‘population fitness’ is removed from the experiment and the individual mutants 
must rely on their own genotype-phenotype characteristics for survival.  In addition, the 
droplets allow us to keep the total culture volume quite low, saving on cost and time that 
is a marked improvement compared to the next best compartmentalization tool, which is 
the microtiter plate.  
 
Experimental design. 
In this study we setout to develop both a droplet-microfluidics system and a low input 
Illumina DNA library preparation for Tn-seq with the purpose of: 1) studying how the 
fitness of individual bacteria are influenced by culture in a dynamic population, and 2) 
studying the impact the microcolony mode of growth has on bacterial fitness.  We first 
adapt and characterize a microfluidics system which produced monodisperse water-in-oil 
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droplets at rates upwards of 1000 droplets/sec. Single S. pneumonia cells can be 
encapsulated in droplets and cultured over time, which does not affect the growth profile 
compared to standard liquid growth.  In addition to planktonic growth in liquid droplets, 
we develop a complementary assay for microcolony-like growth in agarose droplets.  The 
ability to culture microcolonies is critical since most antibiotic studies are performed 
using planktonic cultures even though most naturally occurring bacteria survive in 
higher-order structures, such as microcolonies and biofilms.  We show some basic 
characteristics of microcolony-like growth in agarose droplets across three different 
species of bacteria including S. pneumoniae, Acinetobacter baumannii, and Streptomyces 
roseosporus.  Finally a low input Illumina DNA library method for Tn-seq was tested 
against nanogram and picogram amounts of DNA and then processed through an Illumina 
next-generation sequencing platform. The resulting sequence data is analyzed using 
scripts developed in-house and the number of sequencing reads is used to generate fitness 
data for different low DNA input amounts and correlated to the traditional Tn-seq 
preparation method.   
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METHODS 
Microfluidic Device fabrication 
Microfluidics devices are developed by applying poly(dimethyl siloxane) (PDMS) to a 
microfabricated silicon mold.  The silicon mold is a generous gift from the lab of David 
A. Weitz at Harvard.  The pattern for generating the mold is designed using autoCAD 
software (Fig. 1). A PDMS mold is generated by mixing PDMS and curing agent (Dow 
Corning, Sylgard 184) in a 10:1 ratio and mixing vigorously with a fork.  The mixture is 
added into the silicon mold and degassed with a vacuum for 20 min and cured at 65°C 
overnight. Cured PDMS is cut out of the mold with a scalpel and the non-patterned side 
of the slab covered with scotch tape. A biopsy punch (0.75mm – Shoney Scientific) is 
used to create ports for the tubing (PE-2 tubing – Intramedic). The PDMS slab is then 
bonded to a glass slide (Corning – 2947, 75x50mm) at a cleanroom facility. First the 
glass is cleaned with acetone and methanol in a sonicator bath while the PDMS is cleaned 
with methanol, and then all materials are thoroughly dried with filtered nitrogen gas.  The 
channel side of the PDMS slab and the glass slide are treated with plasma (400sccm flow; 
400 watts; 60 sec) using a faraday barrel screen.  Plasma treated surfaces are quickly 
brought into contact and held together using even pressure across the entire PDMS 
surface by sandwiching the chip between two large glass plates and pressing down on a 
table.  After 2-5 minutes of applying pressure the device is placed at 65°C for 10 minutes 
to complete the bonding. 
  
Microfluidic Device treatment and Droplet production 
Before droplet production the devices are treated with the water-repellent Aquapel 
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(Aquapel - item# 47100). Channels are first primed with fluorinated oil (Novec 7500 oil; 
3M – cat# 98-0212-2928-5) by connecting a 1-ml syringe (Luer-Lok Tip; BD – ref# 
309628) with an attached 27-G needle (BD – ref# 305109) to the oil inlet port using PE-2 
tubing (Fig. 1.1). The channels are then primed with Aquapel using a 5ml SGE Gastight 
syringe (Fisher - SG-008760). The channels are incubated in Aquapel for 10-30 seconds 
before flushing with Novec 7500.  Devices are used immediately or incubated overnight 
at 65°C and then stored in the dark for several weeks before use. Syringe pumps are used 
to push reagents into the microfluidic device to create droplets.  First a 1-ml oil syringe is 
filled with 1.5% of PicoSurf 1 (Dolomite; 3200214) and attached to the oil inlet port (Fig. 
1.1) using PE-2 tubing.  The flow rate is set to 750 µl hr-1 and pushed through the device 
until the oil exits the droplet outlet port (Fig. 1.5), at which point PE-2 tubing is attached 
to the outlet port.  Flow through is collected in a 1.5ml microcentrifuge tube.  While the 
oil phase is still being pushed through, the aqueous phase is first prepared by filtration 
through a 0.22µm syringe filter and then filling a separate 1-ml syringe. PE-2 tubing is 
connected to aqueous syringe, primed with a 500 µl hr-1 flow rate, and then attached to 
the aqueous inlet port (Fig. 1.2).  Droplet production is observed in real-time with a light 
microscope. 
 
Bacteria strains, growth, and media 
Experiments are performed using three S. pneumoniae strains: TIGR4 (NCBI Reference 
Sequence: NC_003028.3); Taiwan-19F (NC_012469.1); D39 (NC_003098.1), as well as 
two additional species: Acinetobacter baumannii (CP000521.1) and Streptomyces 
roseosporus (GCA_000156695.2). Except for Tn-seq experiments S. pneumoniae strains 
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are cultured statically in Todd Hewitt broth supplemented with yeast extract (THY) plus 
5 µl/ml Oxyrase (Oxyrase, Inc) and catalase (Worthington Bio Corp LS001896), or on 
Sheep’s blood agar plates at 37°C in a 5% CO2 atmosphere. A. baumannii is cultured in 
Luria-Bertani (LB) broth or on LB agar at 37°C.  S. roseosporus is cultured in LB broth 
or LB agar at 30°C. 
 
Transposon library construction 
Library construction using the mariner transposon Magellan6 is performed as previously 
described19,23,24.  The transposon lacks transcriptional terminators allowing for read-
through transcription, and additionally has stop codons in all three frames in either 
orientation to prevent aberrant translational products.  Six independent transposon 
libraries are produced for each S. pneumoniae strain (TIGR4, Taiwan-19F, D39).  Each 
library consists of approximately 10,000 total mutants.     
 
Culture of Bacteria in droplets 
Bacteria are cultured to exponential phase before diluting and encapsulating into either 
liquid or agarose droplets.  For liquid droplet culture experiments in which growth curves 
are generated (i.e. Tn-seq libraries, antibiotic treatments), culture is performed in semi-
defined minimal media (SDMM)23 at pH 7.3 supplemented with 20 mM glucose. For Tn-
seq, input samples are collected before encapsulation, and the sample is split for either 
standard pooled culture or droplet encapsulation. Standard pool culture is diluted to an 
initial OD600 of 0.003 (5million cells/ml), while droplet devices are seeded with a 
concentration of 50 million cells/ml. The standard conditions for producing liquid 
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droplets are 500 µl hr-1 aqueous flow rate and 750 µl hr-1 oil rate unless otherwise noted.  
Encapsulation is performed for 15 minutes for all liquid droplets experiments. Liquid 
droplets are cultured at 37°C and 5%CO2 atmosphere unless otherwise noted. To produce 
growth curves from liquid droplet culture small fractions of the entire droplet culture are 
collected at different time points and broken open with 1H,1H,2H,2H-perfluoro-1-octanol 
(PFO; Sigma-Aldrich, cat. no. 370533) and subsequently plated on agar for live cell 
counts. At the end of culture a fraction of the droplets is observed under a Zeiss Axioplan 
2 microscope and the remainder is used for genomic DNA extraction isolated using the 
DNeasy kit Blood and Tissue Kit (Qiagen – 69506) with modifications. To generate 
agarose droplets the entire droplet production system is placed in a 37°C room. A 1.5% 
agarose (Sigma Type IX-A, Ultra-low Gelling Temperature) mixture is made using 
growth media and then heated until dissolved.  The agarose is then filter sterilized 
(0.22µm) after which the cells are added to the agarose solution. The same series of 
encapsulation steps are then taken as with production of liquid droplets, except that the 
standard flow rate for agarose droplets is 1000 µl hr-1 oil rate and 250 µl hr-1 aqueous 
rate.  Droplets are then either cultured under the bacteria’s most optimal growth 
temperature conditions, or placed below room temperature (<20°C) for at least 30 
minutes to allow for agarose gelling. 
 
DNA sample preparation and Illumina sequencing 
Tn-seq DNA sample preparation is performed depending on high (>500ng) or low 
(<500ng) DNA input amounts. High DNA inputs amounts (>500ng) are prepared with a 
traditional Illumina preparation method for Tn-seq as previously described20,22. Low 
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DNA input amounts (<500ng) are prepared by the following method: A 5’ biotinylated 
primer complementary to the transposon inverted repeat sequence (Table 1; Bio-
TEG_P1_M6_MmeI_Short) is used to generate single-stranded DNA (ssDNA) using 
NEB Q5 high-fidelity polymerase in a 20µl reaction with 8% polyethylene glycol 8000 
(PEG 8000) with the following incubation: 98°C for 2 min, followed by 50 cycles of 30s 
at 98°C, 5s at 53°C.  ssDNA product is incubated with 20ul of Ampure XP beads 
(Beckman Coulter - A36880) for 20 minutes and washed three times in 70% EtOH.  
DNA is eluted off of the beads and resuspended in second strand synthesis buffer [1X 
random hexamers (Sigma 11277081001), 1X NEB2 buffer, 5 units NEB Klenow exo-, 
0.5mM dNTP, 8% PEG 8000] and incubated for 30min at 37°C followed by 20min at 
75°C.  The sample is cleaned one more time on Ampure XP beads before being incubated 
with 20ul of streptavidin beads (ThermoFisher - Dynabeads MyOne Streptavidin C1, cat 
# 65001) at room temperature for 1hr.  Streptavidin beads with bound DNA are washed 
twice with binding and washing (B&W) buffer (1M NaCl, 0.5mM EDTA, 5mM Tris, pH 
8) followed with two washes in dH2O. Streptavidin beads are resuspended in MmeI 
digestion buffer (2 units NEB MmeI enzyme, 50µM SAM, 1X CutSmart, 8% PEG 8000) 
and incubated for 2.5hrs at 37°C followed by 20min at 65°C.  1µl of alkaline phosphatase 
(NEB - M0290S Calf Intestinal, CIP) is added to beads and incubated for 1hr at 37°C.  
Adapters are made by mixing and equal volume of primers ADBC-F and ADBC-R 
(Table 1) that are each at 0.2 nM with 1mM Tris and then incubated with the following 
condition: 96oC for 2 min followed by 20-24oC for 10 min. Streptavidin beads are 
washed and added to adaptor ligation buffer (NEB 1X T4 ligation buffer, T4 DNA ligase, 
8% PEG 8000) and 1µl of 6pM adaptor (Table 1) and incubated at 16°C overnight 
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followed by enzyme inactivation at 10min at 65°C. Streptavidin beads are washed and 
the library is finally amplified using NEB Q5 polymerase and a transposon-specific 
primer along with an adapter-specific primer (Table 1; P1M6 and AdptTnseq primers) 
using the following incubation: 98°C for 30sec, followed by 20-26 cycles of 20s at 98°C, 
5s at 62°C, 5s at 72°C, followed by 20s at 72°C.  PCR products are gel purified and 
sequenced on an Illumina NextSeq 500 series sequencer according to the manufacturers 
protocol.   
 
Sequence analysis and Tn-seq fitness calculation 
Sequence analysis is performed with a series of in-house scripts as previously 
described20,22.  The fitness of a single mutant (Wi) is calculated by comparing the fold 
expansion of the mutant to the fold expansion of the population and is determined by the 
following equation as explained previously20: 
𝑊! =  ln 𝑁! 𝑡! ×𝑑/𝑁! 𝑡!  ln ((1− 𝑁! 𝑡! )×𝑑/(1− 𝑁! 𝑡! )) 
Wi takes into account the average fitness value across all insertions within one gene, and 
standard deviation as well as a weighted average allow for the determination the most 
significant data.  Since fitness is calculated using the expansion factor of the population 
(d), Wi becomes independent of time, therefore allowing comparisons between different 
strains and conditions across different experiments.  gDNA from mutant libraries in 
which we already had traditional Tn-seq fitness data were used to test the new library 
preparation explained above.  In this way correlations of fitness values could be made 
between the previous data and the new preparations to assess quality and composition. 
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Additionally genes that had at least one insertion were compared between low input 
preparations and the traditional preparation.  
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RESULTS & DISCUSSION 
 
Significant progress was made in two critical parts of a new Tn-seq workflow (Fig. 2) 
which were: 1) characterizing the production of picoliter-sized droplets through a 
microfluidics device (Fig. 2a-b), and 2) a new Illumina sample library preparation 
method for low input amounts of DNA from Tn-seq libraries (Fig. 2c-e). To characterize 
the droplet-based microfluidics system an in vitro technique was used to generated a 
complex library of mutants using the Mariner Himar1 mini-transposon derivative 
magellan6 as previously described20.  The magellan6 transposon inserts into TA sites and 
results in pooled libraries of mutants where each bacterium contains one insertion (Fig. 
2a).  Culturing of bacteria was performed in picoliter-sized droplets and compared to 
standard batch culture, which is normally used for Tn-seq20 (Fig. 2b).  The small droplet 
volumes generated by a microfluidics system allowed for the isolation and culture of 
single mutants from the pool, which must rely on their own phenotype-genotype 
characteristics for survival.  Because of the small amounts of genomic DNA that were 
recovered from these droplets, we subsequently developed and validated a novel low 
input Illumina sample preparation method, which was performed on genomic DNA from 
three independent Tn-seq libraries from the Streptococcus pneumoniae strain TIGR4 
(Fig. 2c-e). 
I) Droplet Tn-seq workflow: Library culture in droplets, sequencing, and fitness 
calculations. 
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One goal of this study was to evaluate how the growth of individual bacterial strains is 
influenced when grown in a mixed batch culture.  The first step to address this question 
was to utilize an assay that separates out complex mixtures of bacteria. Droplet 
microfluidics has been utilized by other groups for single-cell analysis through the 
compartmentalization of individual bacteria25–29.  These studies have been used to 
manipulate and study single cells in a variety of ways including transfection, directed 
evolution, gene expression analysis, RNA-sequencing, enzymatic activity, and genome 
analysis30. Besides the ability of droplet-microfluidics to separate a bacterial culture into 
single cells, we hypothesized that it would be highly complementary to Tn-seq, enabling 
high-throughput single-cell genomic analyses. 
 
II-A) Monodispersity of liquid droplets.  
First a microfluidics device (Fig. 1) was generated and tested for the droplet 
encapsulation of a liquid aqueous phase into an oil-surfactant mixture.  It was critical that 
the droplets being produced were monodisperse, meaning that all the droplets are of 
uniform size.  Monodispersity of droplets was essential to prevent biases in bacterial 
growth due to varied abundance of resources across each droplet. Microfluidic liquid 
encapsulation produced droplets with diameters that had an average coefficient of 
variation (CV) of 2.7%.  This distribution is well within the acceptable range found in 
II) Development and characterization of a droplet-based microfluidics system to 
generate liquid droplets.  
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other studies28, which should not influence growth between different droplets simply due 
differences in volume.   
 
II-B) Frequency of production, capacity, and stability of liquid droplets. 
The production frequency and the size of the droplets that were produced were controlled 
by altering the flow rates of the oil and aqueous phases. The oil flow rate ranged between 
625-1000 µl hr-1 and the aqueous flow rate ranged between 150-500 µl hr-1. Since the 
speed and size of the droplets were controlled by the ratio of the oil flow rate to the 
aqueous flow rate we represent this value with an Oil:Aqueous flow ratio (OAR). The 
standard OAR used for a majority of the experiments included in this study was 1.5 OAR 
(750 µl hr-1 oil: 500 µl hr-1 aqueous), which generated droplets of 40.5 µm ± 1.1 µm in 
diameter or 35 pL ± 0.7 pL in volume.  With this flow rate frequencies of approximately 
4000 droplets/sec was generated, and in a standard encapsulation time of 15 minutes that 
produced approximately 3.5 x 106 droplets, which rivals frequencies produced by other 
groups31. Droplet production was tested across a range of flow rates and found an 
achievable OAR range of 1.25-6.67 (625–1000 µl hr-1 oil : 150-500 µl hr-1 aqueous) 
without device failure.  This allowed the production of droplets that ranged in size from 
34µm in diameter (20.5 pL) to 42µm in diameter (39 pL) (Fig. 3a-b).  The average 
standard deviation in size of droplets for all tested flow rates was 1.3µm in diameter.  The 
results for generating liquid droplets were highly reproducible and OAR correlated well 
with diameter of the droplets (R2 = 0.82; Fig. 3c). Importantly, droplets were stable for 
several days at different growth temperatures including 37°C which is the optimal 
temperature for our model organism, Streptococcus pneumoniae. Additionally, droplets 
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were stable under slow shaking conditions (10-50rpm) over several days.  Shaking is 
advantageous because droplets are encapsulated in fluorinated oil, which is gas 
permeable.  Thus continuous shaking allows for even gas exchange, which permits the 
uniform growth of aerobic species that must be cultured non-statically.     
 
After developing optimal conditions for generating monodisperse liquid droplets the 
culture of individual bacteria in pico-liter sized compartments was compared to that of 
standard batch culture.  Batch culture represents a complex environment in which many 
different bacteria are able to interact with each other.  One of the goals in this thesis was 
to develop an assay to determine how interactions among mutants in a population affect 
each other’s behavior. To solve this problem we took a reductionist approach, where the 
problem (population of mutants) is split into its simplest parts (individual mutants) and 
each is studied independently. 
 
III-A) Separation of a complex pool of cells into droplets based on a Poisson 
distribution. 
A reductionist approach was applied to a population of cells by using droplet 
microfluidics to split every individual cell into an independent growth environment.  
Assuming that loading rate was constant we can predict the load occupancy of the 
droplets based on a Poisson distribution32 (Fig. 4). If encapsulation is completely random 
than the probability of finding x number of cells per droplet can be predicted using the 
III) Fine tuning of liquid droplet culture conditions for three different strains of 
Streptococcus pneumoniae in the absence and presence of an antibiotic. 
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equation P(X = x) = e-λ[λx/x!], where λ represents the mean number of cells per droplet 
volume. Therefore, using an initial mean number of 0.3 cells per volume (7.5x106 
cell/ml) reduces the chances of getting 2 cells or more in one droplet to ~3%.  At this 
concentration approximately 23% of the droplets will contain one cell and 74% will 
contain no cells.  Thus, to empirically determine if a majority of our droplets that are 
occupied contain just a single cell we simply needed to determine what percentage of our 
droplets were empty. Loading the droplets with a culture that had an absorbance (OD600) 
of 0.03 gave ranges of empty droplets from 85%-70% (Fig. 5) depending on the bacterial 
strain used and how vigorously the sample was vortexed before encapsulation.  These 
results are reasonable considering that different strains have slightly different cell 
numbers at the same OD600 and that vortexing causes cellular chains of S. pneumoniae to 
be broken up resulting in an increase in the observed live cell concentration.    
 
III-B) Growth profiles of 3 different S. pneumoniae strains in liquid droplets. 
Next the culture rate of S. pneumoniae in droplets was compared to that of batch culture.  
For this growth was tested between three S. pneumonia strains (TIGR4, D39, and 19F) 
that differ in their relatedness (Fig. 6). Droplets were loaded with a concentration of 
approximately 7.5 x 106 cell/ml in a semi-defined minimal media (SDMM).  
Encapsulation was performed for 15 minutes resulting in a predicted total of 3.5 x 106 
droplets of which 7.5 x 105 were predicted to be filled with a single cell.  Cells were 
cultured at 37°C and samples were collected and plated on blood agar plates over a 
period of 8hrs.  Growth curves revealed that strains did expand in droplets and that these 
growth profiles had similar trends to batch culture (Fig. 7).  Further experiments showed 
	19	
that bacteria cultured in droplets do lag somewhat in growth compared to batch culture 
and that a greater than 10-fold expansion can be achieved in batch culture (on average 
approximately 300 fold expansion) compared to that in droplets (on average 
approximately 30 fold expansion).  This phenomenon is likely due to waste products, 
such as hydrogen peroxide, building up much more quickly in the droplets compared to 
the large diffusion space offered by batch culture.  Growth differences between droplet 
and batch culture may also be due to differences in buildup of quorum sensing 
molecules26.    
 
III-C) Genomic DNA extraction from one droplet culture experiment. 
Initial tests also found that the total amount of genomic DNA that could be extracted 
from one droplet experiment was approximately 10ng.  This is a critical factor because 
we want to prepare this DNA sample for transposon sequencing and we discovered that 
yields this low make it difficult to successfully generate an Illumina sequencing library.  
One simple solution may be to encapsulate for longer times, which would generate 
greater numbers of encapsulated cells and therefore lead to a higher DNA yield. Although 
this solution is impractical considering the doubling time for S. pneumoniae (~35min) 
and the long encapsulation time that would be necessary (>15min).  Cells that would be 
encapsulated at the very beginning of droplet making would have already have gone 
through nearly one doubling inside of the droplets compared to those encapsulated 
towards the end of the droplet making.  This would generate a heterogeneous cell-growth 
state across droplets and skew true fitness values of independent mutants.  
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III-D) Growth profiles of S. pneumoniae in liquid droplets in the absence and 
presence of Penicillin.  
S. pneumoniae cells were then cultured in droplets and compared to batch culture under a 
stress response.  Penicillin G was chosen as an antibiotic stress due to its clinical 
application in the treatment of S. pneumoniae infections33–35.  Also using a new approach 
to discover genetic factors associated with Penicillin stress would be advantageous 
considering the widespread resistance to this drug acquired by S. pneumoniae36,37. The S. 
pneumoniae strain TIGR4 (T4) was treated in the absence and presence of Penicillin 
(0.0165ug/ml – 0.2ug/ml) in both droplet and batch culture.  It was observed that the 
antibiotic inhibitory range of T4 in the presence of Penicillin was similar between droplet 
and batch culture (Fig. 8).  This was somewhat unexpected considering that S. 
pneumoniae already showed signs of inhibited growth in droplets demonstrated by the 
reduced expansion factor compared to batch culture in the absence of Penicillin.  Then 
again Boedicker et al. and other groups have successfully established antibiotic 
susceptibility testing of bacteria in droplets25, proving that antibiotic treatment in droplets 
should be representative of batch culture.   
 
In addition to using a microfluidics system to generate monodisperse liquid droplets, 
conditions were also developed to produce monodisperse agarose droplets.  Agarose 
droplets are appealing for a number of reasons including: 1) the ability to replenish 
nutrient resources for encapsulated cells28, 2) providing encapsulated cells with a solid 
IV) Modification of the droplet-based microfluidics system to generate agarose 
droplets. 
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matrix for adhesion28,38, 3) creating double encapsulations including agarose-in-aqueous-
in-oil (ag/aq/o) droplets or an agarose-in-agarose-in-oil (ag/ag/o) droplets, or 4) the 
ability to sort encapsulated cells by FACS without having to re-inject droplets into the 
device to create water-in-oil-in-water (w/o/w) droplets. While all of these applications 
could be used to study bacteria in interesting ways the primary purpose for producing the 
agarose droplet system was to generate an environment where bacteria could form 
microcolonies.  This is critical because most current assays that study antibiotic stress do 
so exclusively with planktonic culture.  By generating agarose droplets that were the 
same size as our liquid droplets we create a well-controlled experiment to compare 
planktonic versus microcolony growth.  We describe the development of agarose droplet 
production and report on a few noteworthy phenotypes we observed. Future experiments 
will entail more in-depth characterization of microcolony development in agarose 
droplets such as growth rate and treatment with antibiotics. 
 
IV-A) Monodispersity of agarose droplets. 
Similar to the liquid droplets optimal encapsulation conditions were determined for 
agarose including the range of flow rates and the distribution of droplet sizes that could 
be generated.  It was discovered that a crucial factor in the production of monodisperse 
agarose droplets was the careful control of temperature during encapsulation. The most 
consistent agarose droplet sizes were generated by using an Ultra-low melting 
temperature agarose in a 37°C environment.  The constant 37°C temperature prevented 
the agarose from experiencing minor fluctuations in viscosity during encapsulation, 
therefore allowing consistent droplet formation.  Although the gelling temperature of the 
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ultra-low melting agarose was below room temperature, performing the encapsulation at 
22°C produced polydisperse droplets and device failure due to delamination of the PDMS 
device.  It was discovered that the variability in agarose droplet size (CV = 7%) under 
multiple different flow rates was larger than that of liquid droplets.  Although the agarose 
droplet size variance was larger than in liquid droplets the volumetric range still well 
within that found by other studies that have produced agarose droplets29,38.   
 
IV-B) Frequency of production and capacity of agarose droplets. 
The operational range of OA flow ratios for agarose droplet production is 1.50-8 (750-
1000 µl hr-1 oil rate; 125-500 µl hr-1 aqueous rate), which is similar to that of liquid 
droplets. There was a very poor linear correlation between OAR ratios and agarose 
droplet diameter (Fig. 9).  This indicates that there are either critical, but yet to be 
identified, procedural factors that are changing from experiment to experiment, or that the 
relationship between flow rates and droplet diameters is not truly linear, which some 
studies have suggested39.  Additional testing is required to find out the reason behind this 
variability.  Since flow rate is a good predictor of droplet size, it should be controlled 
more carefully for agarose droplet production.  The syringe pumps are not likely the issue 
because the same pumps are used for both liquid and agarose droplet production. Another 
critical factor for flow rates is the hydrophobic treatment of the channels prior to 
encapsulation.  The exact residence time of the hydrophobic treatment is not known, so 
degradation of the hydrophobic interactions could be a likely reason behind agarose 
droplet size variation.  
	23	
Additionally it was observed that the agarose droplet size was much smaller than that of 
liquid droplets under similar OAR conditions (21 µm - 34 µm in diameter or 5 pL - 20.5 
pL in volume) (Fig. 9).  This may be due to the extra drag caused by the agarose polymer 
against the sides of the channels. The drag would slow down the flow rate of the aqueous 
phase, causing the observed OAR ratio to be higher than expected which would produce 
smaller droplets.  Efforts to try to increase the aqueous rates beyond the described 
thresholds to overcome this proposed drag resulted in device delamination and failure due 
to extreme pressures.  If we could determine the factor that controls the variation in 
agarose droplet size from experiment to experiment, we could consistently generate 
similar sized agarose and liquid droplets (~35um or 22pL) with the current device.  This 
would allow us to accurately compare planktonic and microcolony culture with the only 
variable being the agarose matrix, and with no other confounding variables, which would 
be a marked improvement over other types of microcolony assays40,41. 
The number of agarose droplets produced in a certain amount of time could not be 
determined due to the variation in the production. However it can be concluded that more 
consistent sized agarose droplets can be made with aqueous flow rates at or below 250 
µl/hr.  When the collective variances are averaged below or equal to an aqueous flow rate 
of 250 µl/hr the CV decreases from 7% to 5.8%, while flow rates above 250 µl/hr have a 
collective CV average of 8.9%.  This indicates that monodisperse agarose droplets cannot 
be produced as quickly as liquid droplets in the same microfluidics device. It is also 
worth noting that droplets have been generated using different concentrations of agarose 
from 1-2%.  However these concentrations have not been systematically tested to 
determine the overall affect on droplet generation. 
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It is well documented that microcolony attachment and aggregation is the first step in 
biofilm formation42,43. Communal modes of growth, such as biofilms and microcolonies, 
are known to contribute to resistance against stresses such as antibiotics. However most 
antimicrobial studies are routinely performed using planktonic cells.  Therefore there is a 
need to develop assays to address the impact of microcolony formation on the 
antimicrobial stress response of bacteria.  Here we develop a microcolony-like growth 
assay in agarose droplets that is complementary to the liquid droplet assay described 
previously. The effects of growth in agarose droplets were tested across three bacterial 
species with different characteristics: S. Pneumoniae (gram positive), Acinetobacter 
baumannii (gram negative), and Streptomyces roseosporus (filamentous actinobacteria).  
First S. Pneumoniae was encapsulated as single cells or at high density in 1.5% agarose 
in THY media.  Droplets were cultured at 37°C and 5% CO2 and DIC images were taken 
at 4hrs and 20hrs (Fig. 10).  When seeding droplets with single cells it was noticed that 
microcolonies approximately 10µm in size were produced after 4hrs.  Microcolony 
formation was not observed in droplets seeded in a high density after 4hrs.  Nutrient 
depravation, waste product build-up, or quorum sensing activity may account for this 
phenotype.  After 20hrs of growth microcolonies that were produced in droplets seeded 
with single cells remained relatively intact while cells in the high-density droplets looked 
like they had undergone cell death.  The most likely reason for cell death is hydrogen 
peroxide buildup, which is a well-known characteristic of S. Pneumoniae, which keeps it 
V) General characteristics and notable phenotypes observed in microcolony 
development across different bacterial pathogens. 
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from having a stable stationary phase.  This still begs the question as to why the 
microcolonies remained visually intact even though hydrogen peroxide was also building 
up over a 20hr period.  More tests will be needed to answer these questions.  We did 
however determine basic growth requirements in agarose droplets for S. pneumoniae, 
which include a short culture time (4-6hrs) and would likely be more optimal if we 
removed the oil and refreshed the media after several hours. 
A. baumannii was seeded as single cells or at high density into 1.5% agarose droplets in 
LB media.  These droplets were then incubated at 37°C for 24hrs at which point DIC 
images were taken (Fig. 11).  The oil was then removed from the droplets using PFO and 
the droplets were put into fresh LB.  After 48hrs of total growth more DIC images were 
taken (Fig. 11).  A. baumannii has much more robust and uniform microcolony growth 
compared to that of S. pneumoniae.  Additionally hearty A. baumannii microcolonies are 
formed in droplets seeded with both single cells and at high density, albeit high-density 
droplets have microcolonies that are smaller in size compared to that of droplets seeded 
with single cells.  This difference in microcolony size may have to do with nutrient 
limitations.  To prove that active growth could be re-establish we removed the oil and put 
the agarose droplets into fresh media.  The observation of microcolonies expanding to a 
larger size in the high density condition by 48hrs total growth compared to droplets in 
which oil was not removed (not shown) demonstrated that fresh nutrients could replace 
waste products inside droplets and trigger active growth (Fig. 11).  Interestingly intact 
microcolonies could not be found in droplets that were initially seeded with single cells 
after 48hrs with oil removal and nutrient replacement.  Instead only droplets that had 
tears in them were found.  These torn droplets looked like they had at one point harbored 
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a microcolony. Those droplets that were seeded with many cells and therefore had many 
microcolonies in them remained intact while ones that were seeded at single cell density 
and had very few colonies tore through and escaped the confinement of the agarose. We 
therefore speculate that this “escape” phenomenon is density dependent. It is exciting to 
think this observation occurred due to a signaling molecule that controls microcolony 
dispersal.  At higher density there may be more of this molecule around to signal the 
bacteria to prevent dispersal.  When this molecule is lacking the bacteria may trigger 
twitching or swarming motility to escape the droplet; and there is evidence that 
extracellular conditions can strongly regulate motility in A. baumannii44.   If identified 
this molecule could be taken advantage of to prematurely disperse microcolony structure 
of A. baumannii, which could theoretically make these bacteria more susceptible to 
antibiotics. 
S. roseosporus is used here because it represents a dynamic group of filamentous soil 
bacteria that are responsible for a majority of our current antibiotics45.  S. roseosporus 
itself produces the precursor to the novel antimicrobial Daptomycin46.  Although the 
precursor to Daptomycin is not studied directly here we determined growth 
characteristics of S. roseosporus in agarose droplets that build the foundation for future 
studies of the precursor.  First S. roseosporus spores were produced.  This was necessary 
because S. roseosporus cells divide in long continuous filaments, which make it difficult 
to seed individual cells in separate droplets. Spores were used to seed droplets that 
contained different concentrations of agarose (0%, 1%, 1.5%, and 2%) and cultured at 
30°C for 48hrs.  Fascinatingly S. roseosporus filaments punctured through the oil layer at 
higher concentrations of agarose (Fig. 12).  A likely explanation for this is that S. 
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roseosporus can push better off of the denser agarose matrix and can use the apical end of 
a single filament to penetrate through the oil.  Although this explanation hypothetically 
makes sense it is still curious considering the seemingly opposing interactions that would 
occur between the oil and the cell membrane.  Ultimately optimal growth conditions for 
culturing and retaining S. roseosporus in agarose droplets was found, which is seeding in 
1% agarose and culturing at 30°C for 48hrs.  
 
A major drawback in the production of good quality DNA libraries from transposon 
insertion mutants is the need for high input amounts of DNA20.  Therefore assays in 
which only a small amount of DNA is recovered, like single-cell genomics and in-vivo 
experiments, require further manipulation after the primary culture cycle in order to 
generate enough DNA for sequence preparation.  In the case of Tn-seq these 
manipulations require either: 1) the continued proliferation of cells on solid media or, 2) 
an increase in the number of PCR cycles to amplify the final DNA library.  Both of these 
methods can skew the data representing the distribution frequency of mutants in the 
population.  Therefore a new method was establish to generate Tn-seq DNA libraries 
from low DNA inputs by enriching genomic DNA near transposon ends with a single 
stranded DNA PCR using a biotinylated primer.  The DNA was then cleaned up with 
solid phase reverse immobilization (SPRI) beads and then bound to streptavidin beads for 
adaptor ligation (Fig. 2c-d).  
 
 
VI) Development and validation of a novel low-input Tn-seq DNA library 
preparation method. 
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VI-A) Enrichment of transposon ends using a biotinylated oligo. 
Biotinylated oligos can be used for Pyrosequencing, SNP analysis, solid-phase DNA 
sequencing, and a number of other applications in which the strong streptavidin-biotin 
bond is used to immobilize or enrich DNA molecules.  Biotinylated oligos have also been 
used to successfully generate single stranded DNA libraries from ancient or damaged 
DNA47. Biotinylated primers are used here to enrich transposon ends from DNA of a 
complex transposon mutant library. This technique has been utilized previously by 
Goodman et al. in a method called Insertion sequencing (INSeq)48.  The lower limit of 
DNA input for this method is 500ng.  Due to the limited amount of DNA recovered for 
some growth experiments, such as in-vivo colonization and the single-cell genomics 
assay described in this study, it was necessary to develop a low input DNA library 
preparation that was sensitive down to 10ng or less. 
 
VI-B) PCR validation of library preparation using a combination of SPRI beads 
and streptavidin beads. 
It was determined that the difficulty in enriching a genomic region using a biotinylated 
primer is due to excess unused primer. The unused biotinylated primer could bind 
streptavidin beads and caused unwanted PCR products.  Once the unused primer was 
bound to the beads the unbiotinylated end was still able to ligate to a sequencing adaptor, 
which is a necessary step in library preparation.  During library preparation this direct 
primer-adaptor ligation outcompeted the development of the true library and created a 
product that was ~20bp smaller than the true library size (Fig. 13a).  By cleaning up the 
reaction with commercially available SPRI beads (Ampure XP beads) directly after the 
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enrichment with the biotinylated primer, excess biotinylated primer was removed to 
prevent the unwanted PCR product. Ampure bead removal of excess unused primer was 
verified by performing a library preparation in the absence and presence of genomic 
DNA from a transposon library (Fig. 13).  In the absence of genomic DNA there were no 
amplified PCR products, while in the presence of genomic DNA a PCR product of the 
predicted library size is generated.  Also the amount of DNA library that was amplified 
was dependent on the initial concentration of primer used in the first single stranded PCR 
reaction. Additionally since it was shown previously that using poly(ethylene glycol) 
8000 (PEG) can increase the efficiency of enzymatic reactions47 we decided to utilize this 
method for our low input library preparation.  It was determined that more single 
stranded product could be produced from a 20 µl reaction with 8% PEG than in a 50 µl 
reaction in the absence of PEG with holding all other variables constant (data not shown).  
This is why 8% PEG was used in all enzymatic reactions during library preparation.  
Additionally, an advantage of using streptavidin beads during cleanup steps for the low 
input library is the removal of all nonspecific PCR products (Fig. 13).  In the traditional 
preparation nonspecific products are produced at approximately 100bp and 30bp (Fig. 13, 
+ctl).  These nonspecific products are presumably due to excess adapter, which is 
removed during wash steps for the new low input preparation. 
 
VI-C) Validation of the low input Tn-seq DNA library preparation by massively-
parallel sequencing.  
To validate the low input DNA library preparation method three biological replicates of a 
Mariner transposon library produce in an unencapsulated version of TIGR4 (2394) were 
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processed.  These libraries were cultured in SDMM in the presence of glucose. To 
rigorously evaluate the new low input preparation method the same genomic DNA was 
utilized to generate sequencing libraries using the new preparation method for the three 
input amounts (10ng, 1ng, and 100pg) and generate libraries using the traditional Tn-seq 
prep with 3µg of DNA20.   
PCR products of the correct size were generated from the new sequencing preparation 
method with all low input amounts and from the traditional Tn-seq preparation (data not 
shown).  These samples were pooled, processed through the Illumina NextSeq sequencer 
according to the manufacturer’s protocol, and the data analyzed according to a Tn-seq 
workflow previously described20. We were able to successfully extract the number of 
insertions per gene and generate fitness values from this data.  After combining the data 
for all three libraries the quality of our traditional preparation was considered satisfactory 
because the number of insertions per gene correlates extremely well to a separate 
biological replicate experiment using the same library samples (Fig. 14a; R2=0.99). 
Additionally the fitness values correlated well for a biological replicate (Fig. 14; 
R2=0.74,). However there is no correlation between any of our new low input 
preparations and the traditional preparation for either number of insertions per gene or 
fitness (Fig. 14a-b). Additionally when comparing total number of insertions (or unique 
reads) across the genome the low input library preparation had on average 88% fewer 
reads then the traditional preparation.  The reason behind this significant loss in 
robustness in the low input preparation is not due to data being thrown out during 
sequence analysis because 99.9% of all reads were kept after fastq filter and 95% of that 
data was properly demultiplexed.  The reason behind the lack of correlation is thought to 
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be due to the binding site of the biotinylated primer from the initial single stranded PCR.  
The biotinylated primer is complementary to the inverted repeats found on the very ends 
of the transposon.  Therefore the first nucleotide that is incorporated during the single 
stranded enrichment will be in the genomic DNA.  This means that the single stranded 
DNA enrichment could be subjected to bias depending on which nucleotide is 
incorporated.  PCR bias resulting from mixtures of complex templates has been described 
previously49.  Goodman et al. avoid this bias by having the recognition site for single 
stranded PCR be approximately 20bp away from either end of the transposon48.  In this 
way the first 20 or so nucleotides that are incorporated across all transposon insertion 
sites are exactly the same, which reduces PCR bias.  This lack of diversity could also be 
due to a combination of sub-optimal thermal-cycling conditions and poor polymerase 
enzyme kinetics.  To address this a number of different polymerases and thermal-cycling 
conditions will be tested to optimize the technique. Although very poor correlations were 
obtained when comparing fitness values between the new low input preparation and the 
traditional library preparation, we still managed to successfully produce an Illumina 
sequencing preparation technique for Tn-seq samples that works down to picogram 
amounts of DNA input.  Success in the new sequencing preparation is represented by the 
number of genes found with insertions that overlap between the new preparation and the 
traditional preparation (Fig. 14c).         
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CONCLUSIONS 
It is paramount to develop methods that are both accurate and dynamic in the information 
they can provide to us about a biological system.  We first describe a method that could 
reveal the influence of bacterial population fitness on the fitness of individuals within that 
population.  We also describe a method that could reveal the importance of bacterial 
microcolony development in fitness and dealing with a stress response.  Significant 
progress has been made in developing and characterizing critical aspects for both of these 
methods.  We can successfully generate monodisperse liquid and agarose droplets, in 
which we have optimized growth of several clinically relevant pathogens.  Going forward 
it will be necessary to eliminate the variation in the generation of agarose droplets.  We 
are also making strides to generate new microfluidic chips, which can generate larger 
droplets to allow for greater expansion of encapsulated bacteria.  Another new chip 
design could allow us to produce alginate droplets as an alternative to agarose droplets.  
Alginate droplets would be more optimal because they are more biologically relevant, 
considering that some bacteria secrete alginate in biofilms. Additionally alginate droplets 
can be made at room temperature eliminating the need for a warm room and potential 
fluctuations in flow rates, which would reduce droplet size variation considerably.  We 
have also generated a new Illumina sequencing preparation method that is sensitive down 
to sub-nanogram of DNA input.  This is not only important to our new droplet Tn-seq 
method, which only produces nanograms of DNA, but also to other Tn-seq library culture 
methods that generate only small amounts of DNA such as in-vivo studies.  We have 
identified a very likely source to the current bias generated in our low input sequence 
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preparation.  Changing the recognition site of the primer for single stranded PCR 
enrichment should eliminate this problem.   
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FIGURES & TABLES 
 
 
 
 
 
 
 
 
 
Figure 1 | Microfluidic device schematic.  This pattern was used to generate microfluidic 
devices for the encapsulation of both liquid and agarose aqueous phases into a continuous 
oil phase.  Fluids are pumped from syringes through tubing into the oil inlet (1) and the 
aqueous inlet (2). Fluid resistors (3) prevent rapid fluctuations in flow rate downstream in 
the device. Aqueous-in-oil droplets are produced at the flow-focus junction (4) through 
squeezing of the aqueous flow by the oil flow into a dispersed phase. Finally aqueous-in-
oil droplets are collected through the droplet outlet (5) through a tube into a collection 
device.  The device pattern was designed using autoCAD software. 
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Table 1 | List of primers used in the study. 
Name Sequence (5'->3')
Bio-TEG_P1_M6_MmeI_Short /5BiotinTEG/GGGGACTTATCATCCAACCTGT
P1-M6-GAT-MmeI CAAGCAGAAGACGGCATACGAGATAGACCGGGGACTTATCATCCAACCTGT
P2-ADPT-Tnseq-primer AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT
ADBC-F-INDX1a ACACGACGCTCTTCCGATCTGGAACTCCTACTGACNN
ADBC-F-INDX1b ACACGACGCTCTTCCGATCTTAGCACATGCTGACTNN
ADBC-F-INDX1c ACACGACGCTCTTCCGATCTCCTTGAGGATGACTGNN
ADBC-F-INDX1d ACACGACGCTCTTCCGATCTATCGTGTACGACTGANN
ADBC-F-INDX2a ACACGACGCTCTTCCGATCTGACTACCCTCTGGACNN
ADBC-F-INDX2b ACACGACGCTCTTCCGATCTTCTGGATACACTACTNN
ADBC-F-INDX2c ACACGACGCTCTTCCGATCTCTGATGGGAGACCTGNN
ADBC-F-INDX2d ACACGACGCTCTTCCGATCTAGACCTATGTGATGANN
ADBC-F-INDX3a ACACGACGCTCTTCCGATCTGACTGCCACATGAACNN
ADBC-F-INDX3b ACACGACGCTCTTCCGATCTTCTGAATCTCCTGCTNN
ADBC-F-INDX3c ACACGACGCTCTTCCGATCTAGAACGGTGTACTTGNN
ADBC-F-INDX3d ACACGACGCTCTTCCGATCTCTGCTTAGAGGACGANN
ADBC-F-INDX4a ACACGACGCTCTTCCGATCTCGACACTGAACGACCNN
ADBC-F-INDX4b ACACGACGCTCTTCCGATCTTTCTGACTCCTTGATNN
ADBC-F-INDX4c ACACGACGCTCTTCCGATCTGCTGTGACTTGCTGGNN
ADBC-F-INDX4d ACACGACGCTCTTCCGATCTAAGACTGAGGAACTANN
ADBC-F-INDX5a ACACGACGCTCTTCCGATCTACTGCATGCCTTAACNN
ADBC-F-INDX5b ACACGACGCTCTTCCGATCTCTGAAGGAAACGGCTNN
ADBC-F-INDX5c ACACGACGCTCTTCCGATCTTGACGTACGGAATTGNN
ADBC-F-INDX5d ACACGACGCTCTTCCGATCTGACTTCCTTTGCCGANN
ADBC-F-INDX6a ACACGACGCTCTTCCGATCTCCTAAAGGAATGGCCNN
ADBC-F-INDX6b ACACGACGCTCTTCCGATCTATGGCGTACCCTAATNN
ADBC-F-INDX6c ACACGACGCTCTTCCGATCTGGATTTCCTTACCGGNN
ADBC-F-INDX6d ACACGACGCTCTTCCGATCTTACCGCATGGGATTANN
ADBC-F-INDX7a ACACGACGCTCTTCCGATCTCAGACGAGGATTGCTNN
ADBC-F-INDX7b ACACGACGCTCTTCCGATCTACACTTGTACCGAACNN
ADBC-F-INDX7c ACACGACGCTCTTCCGATCTGTCTGCTCCTAACGANN
ADBC-F-INDX7d ACACGACGCTCTTCCGATCTTGTGAACATGGCTTGNN
ADBC-F-INDX7a ACACGACGCTCTTCCGATCTCAGACGAGGATTGCTNN
ADBC-F-INDX7b ACACGACGCTCTTCCGATCTACACTTGTACCGAACNN
ADBC-F-INDX7c ACACGACGCTCTTCCGATCTGTCTGCTCCTAACGANN
ADBC-F-INDX7d ACACGACGCTCTTCCGATCTTGTGAACATGGCTTGNN
ADBC-F-INDX8a ACACGACGCTCTTCCGATCTACGCGAGGACCTACCNN
ADBC-F-INDX8b ACACGACGCTCTTCCGATCTCAATTCTAGATGGATNN
ADBC-F-INDX8c ACACGACGCTCTTCCGATCTTGCGCTCCTGGATGGNN
ADBC-F-INDX8d ACACGACGCTCTTCCGATCTGTTAAGATCTACCTANN
ADBC-F-INDX9a ACACGACGCTCTTCCGATCTCTCAGAAGACCGGATNN
ADBC-F-INDX9b ACACGACGCTCTTCCGATCTAGTGTGCACATTACCNN
ADBC-F-INDX9c ACACGACGCTCTTCCGATCTGAGTCTTCTGGCCTANN
ADBC-F-INDX9d ACACGACGCTCTTCCGATCTTCACACGTGTAATGGNN
ADBC-F-INDX10a ACACGACGCTCTTCCGATCTACCGTACGTATTAATNN
ADBC-F-INDX10b ACACGACGCTCTTCCGATCTCTAAGGAAGCCGGCCNN
ADBC-F-INDX10c ACACGACGCTCTTCCGATCTTGGCATGCATAATTANN
ADBC-F-INDX10d ACACGACGCTCTTCCGATCTGATTCCTTCGGCCGGNN
ADBC-F-INDX11a ACACGACGCTCTTCCGATCTCACTCGGACACGAATNN
ADBC-F-INDX11b ACACGACGCTCTTCCGATCTTCTGATACTCTTGCCNN
ADBC-F-INDX11c ACACGACGCTCTTCCGATCTGGGAGACTATGCTTANN
ADBC-F-INDX11d ACACGACGCTCTTCCGATCTATACTCTGGGAACGGNN
ADBC-F-INDX12a ACACGACGCTCTTCCGATCTCCATACGAGCACTCCNN
ADBC-F-INDX12b ACACGACGCTCTTCCGATCTTTCCGATGTTGAGTANN
ADBC-F-INDX12c ACACGACGCTCTTCCGATCTGGTATGCTCGTGAGGNN
ADBC-F-INDX12d ACACGACGCTCTTCCGATCTAAGGCTACAACTCATNN
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Table 1 continued | List of primers used in the study. 
Name Sequence(5'->3')
ADBC-R-INDX1a /5PHOS/GTCAGTAGGAGTTCCAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS/
ADBC-R-INDX1b /5PHOS/AGTCAGCATGTGCTAAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS/
ADBC-R-INDX1c /5PHOS/CAGTCATCCTCAAGGAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS/
ADBC-R-INDX1d /5PHOS/TCAGTCGTACACGATAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS/
ADBC-R-INDX2a /5PHOS/GTCCAGAGGGTAGTCAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS/
ADBC-R-INDX2b /5PHOS/AGTAGTGTATCCAGAAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS/
ADBC-R-INDX2c /5PHOS/CAGGTCTCCCATCAGAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS/
ADBC-R-INDX2d /5PHOS/TCATCACATAGGTCTAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS/
ADBC-R-INDX3a /5PHOS/GTTCATGTGGCAGTCAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS/
ADBC-R-INDX3b /5PHOS/AGCAGGAGATTCAGAAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS/
ADBC-R-INDX3c /5PHOS/CAAGTACACCGTTCTAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS/
ADBC-R-INDX3d /5PHOS/TCGTCCTCTAAGCAGAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS/
ADBC-R-INDX4a /5PHOS/GGTCGTTCAGTGTCGAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS/
ADBC-R-INDX4b /5PHOS/ATCAAGGAGTCAGAAAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS/
ADBC-R-INDX4c /5PHOS/CCAGCAAGTCACAGCAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS/
ADBC-R-INDX4d /5PHOS/TAGTTCCTCAGTCTTAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS/
ADBC-R-INDX5a /5PHOS/GTTAAGGCATGCAGTAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS/
ADBC-R-INDX5b /5PHOS/AGCCGTTTCCTTCAGAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS/
ADBC-R-INDX5c /5PHOS/CAATTCCGTACGTCAAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS/
ADBC-R-INDX5d /5PHOS/TCGGCAAAGGAAGTCAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS/
ADBC-R-INDX6a /5PHOS/GGCCATTCCTTTAGGAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS/
ADBC-R-INDX6b /5PHOS/ATTAGGGTACGCCATAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS/
ADBC-R-INDX6c /5PHOS/CCGGTAAGGAAATCCAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS/
ADBC-R-INDX6d /5PHOS/TAATCCCATGCGGTAAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS/
ADBC-R-INDX7a /5PHOS/AGCAATCCTCGTCTGAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS/
ADBC-R-INDX7b /5PHOS/GTTCGGTACAAGTGTAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS/
ADBC-R-INDX7c /5PHOS/TCGTTAGGAGCAGACAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS/
ADBC-R-INDX7d /5PHOS/CAAGCCATGTTCACAAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS/
ADBC-R-INDX7a 5PHOS/AGCAATCCTCGTCTGAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS
ADBC-R-INDX7b 5PHOS/GTTCGGTACAAGTGTAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS
ADBC-R-INDX7c 5PHOS/TCGTTAGGAGCAGACAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS
ADBC-R-INDX7d 5PHOS/CAAGCCATGTTCACAAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS
ADBC-R-INDX8a 5PHOS/GGTAGGTCCTCGCGTAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS
ADBC-R-INDX8b 5PHOS/ATCCATCTAGAATTGAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS
ADBC-R-INDX8c 5PHOS/CCATCCAGGAGCGCAAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS
ADBC-R-INDX8d 5PHOS/TAGGTAGATCTTAACAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS
ADBC-R-INDX9a 5PHOS/ATCCGGTCTTCTGAGAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS
ADBC-R-INDX9b 5PHOS/GGTAATGTGCACACTAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS
ADBC-R-INDX9c 5PHOS/TAGGCCAGAAGACTCAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS
ADBC-R-INDX9d 5PHOS/CCATTACACGTGTGAAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS
ADBC-R-INDX10a 5PHOS/ATTAATACGTACGGTAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS
ADBC-R-INDX10b 5PHOS/GGCCGGCTTCCTTAGAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS
ADBC-R-INDX10c 5PHOS/TAATTATGCATGCCAAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS
ADBC-R-INDX10d 5PHOS/CCGGCCGAAGGAATCAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS
ADBC-R-INDX11a 5PHOS/ATTCGTGTCCGAGTGAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS
ADBC-R-INDX11b 5PHOS/GGCAAGAGTATCAGAAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS
ADBC-R-INDX11c 5PHOS/TAAGCATAGTCTCCCAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS
ADBC-R-INDX11d 5PHOS/CCGTTCCCAGAGTATAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS
ADBC-R-INDX12a 5PHOS/GGAGTGCTCGTATGGAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS
ADBC-R-INDX12b 5PHOS/TACTCAACATCGGAAAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS
ADBC-R-INDX12c 5PHOS/CCTCACGAGCATACCAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS
ADBC-R-INDX12d 5PHOS/ATGAGTTGTAGCCTTAGATCGGAAGAGCGTCGTGTAGGGA/3PHOS
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Figure 2 | Schematic of Tn-seq performed utilizing a droplet-based technique. (a) A 
Mariner mini-transposon that contains MmeI sites in the inverted repeat ends is first 
transposed into genomic DNA in vitro and then transformed into a bacterial population.  
Each resulting mutant contains one insertion. (b) DNA is isolated from one portion of the 
cultured transposon mutant pool (t1) while another portion is used for growth selection in 
droplets, after which DNA is collected from these encapsulated cells (t2). (c) To create a 
DNA sequencing library first a biotinylated primer is used to enrich the transposon ends 
using single stranded PCR.  Ampure beads are used to clean the sample from excess 
unused primer. Second strand synthesis is then performed using Klenow fragment. (d) 
Biotinylated double-stranded products are then bound to streptavidin beads. On-bead 
enzymatic reactions are performed that include MmeI digestion, Alkaline phosphatase 
incubation, and adaptor ligation. (e) On-bead PCR amplification is followed by Illumina 
sequencing and mapping.  Samples are identified by barcode sequence from the adaptors, 
and read counts on either side of each mapped transposon insertion allow for fitness 
calculation.     
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Figure 3 | Liquid droplet characteristics.  (A) Differential interference contrast (DIC) 
images of liquid droplets at three different oil/aqueous (Oil:Aq) flow ratios. Scale bar = 
40µm (B) Distribution of droplet diameters at three different OA flow ratios. (C) 
Correlation plot of mean diameter of droplets produced from different OA flow ratios. 
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Figure 4 | Poisson distribution showing the probability [P(x)] of encapsulating x number 
of cells within a droplet at different average number of cells per volume (λ)  
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Figure 5 | Differential interference contrast (DIC) image of S. pneumoniae strain D39 
after 5hrs culture in liquid droplets.  Images were used to count empty droplets to predict 
cell occupancy based on a Poisson distribution. Scale bar = 40µm. 
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Figure 6 | Phylogenetic tree including S. pneumoniae strains used in this study 
(highlighted in red). 
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Figure 7 | Growth profiles of 3 different S. pneumoniae strains in droplets and bulk 
culture (control) over an 8hr time period.  Strains were cultured in semi-defined minimal 
media (SDMM) and plated on blood agar at different time points to determine live cell 
counts. 
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Figure 8 | Growth profiles of S. pneumoniae strain TIGR4 cultured in droplets and bulk 
culture and treated in the absence (No drug) and presence of Penicillin (PEN). Strains 
were cultured in semi-defined minimal media (SDMM) and plated on blood agar at 
different time points to determine live cell counts. 
 
 
 
3 
3.5 
4 
4.5 
5 
5.5 
0 2 4 6 8 
Lo
g 1
0 (
ce
ll 
#)
 
Time (h) 
Droplet Culture 
No Drug 
0.0165ug/ml PEN 
0.023ug/ml PEN 
1.5 
2.5 
3.5 
4.5 
5.5 
0 1 2 3 
Lo
g 1
0 (
ce
ll 
#)
 
Time (h) 
Bulk Culture 
No drug 
0.0165ug/ml PEN 
0.038ug/ml PEN 
	44	
 
 
 
 
 
 
 
Figure 9 | Agarose droplet characteristics.  (A) Phase contrast image of agarose droplets. 
Scale bar = 40µm (B) Distribution of droplet diameters at three different oil:aqueous 
(OA) flow ratios. (C) Correlation plot of mean diameter of droplets produced from 
different OA flow ratios. 
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Figure 10 | S. pneumoniae strain D39 was seeded in 1.5% agarose droplets at either 
single cell or high density.  Droplets were cultured at 37°C, 5% CO2, and DIC images of 
representative droplets were taken at 4hrs and 20hrs. Microcolonies approximately 10µm 
in size were produced after 4hrs in single cell seeding while microcolony formation was 
not observed in droplets seeded in a high density after 4hrs. After 20hrs of growth 
microcolonies that were produced in droplets seeded with single cells remained relatively 
intact while cells in the high-density droplets looked like they had undergone cell death.  
Scale bar = 40µm.  
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Figure 11 | A. baumannii was seeded in 1.5% agarose droplets at either single cell or 
high density.  Cells were culture in oil droplets at 37°C for 24hrs, at which time 
representative DIC images were taken.  Oil was removed using PFO and intact droplets 
were re-submerged in new growth media. At 48hrs total growth DIC images of 
representative droplets were taken. After 24hrs healthy microcolonies develop in both 
single cell and high density seeding conditions, and active proliferation can be re-
established by removing the oil layer and supplying fresh media.  Additionally we 
observe a density dependent “escape” phenotype when cell densities are at single cell 
seeding levels as opposed to high density seeding. Scale bar = 40µm.  
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Figure 12 | S. roseosporus spores were seeded in droplets containing different 
concentrations of agarose (0%, 1%, 1.5%, and 2%).  Droplets surrounded in oil were 
cultured at 30°C for 48hrs after which representative DIC images were taken.  It seems 
that S. roseosporus can push better off of denser agarose matrix and can use the apical 
end of a single filament to penetrate through the oil. Scale bar = 40µm.  
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Figure 13 | PCR results of new low-input DNA library preparation. (A) Without SPRI 
bead clean up a product that is approximately 20bp smaller (red arrow) than the correct 
library size (white arrow) is produced. (B) DNA libraries produced in the absence (-) or 
presence of indicated amounts of DNA.  Final biotinylated primer concentrations used for 
single stranded PCR enrichment are shown. SPRI bead cleanup is used for all conditions. 
The incorrect PCR product size due to direct primer-adaptor binding is prevented by 
SPRI bead clean up (-DNA), while a band matching the correct library size was produced 
under the same conditions in the presence of 10ng and 100ng of genomic DNA. A library 
generated using the traditional Tn-seq preparation method is shown (+CTL).  The use of 
Ampure beads and the concentration of biotinylated primer are critical components for 
producing an Illumina library of DNA molecules of the correct size. 
 
 
 
 
 
 
 
 
 
 
 
	49	
 
 
 
 
 
Figure 14 | Data comparing number of insertions per gene and fitness (W) between a new 
low input Tn-seq DNA library preparation to the traditional library preparation.  Data 
from new preparations does not correlate to traditional library preparations because of a 
low diversity of reads obtained from the new preparation. (A) The number of insertions 
per gene from a traditional Tn-seq preparation (Traditional Control) is correlated to a 
biological replicate (Traditional Replicate) and to three low input library preparations 
(10ng, 1ng, and 0.1ng). Only genes that had greater than 5 insertions were plotted. (B) 
Fitness values for a traditional Tn-seq preparation (Traditional Control) are correlated to 
a biological replicate (Traditional Replicate) and to all three low input library 
preparations (10ng, 1ng, and 0.1ng).  Gene fitness was only plotted if data was obtained 
for that gene in both data sets. (C) Each set of genes that contained at least 1 insertion 
where compared between the low input preparations and the traditional preparation (Trad 
Ctl). 
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